Prophylactic metformin after antenatal corticosteroids (PROMAC): a double blind randomized controlled trial

• Egile Nagusiak: Jesrine Gek Shan Hong (Egilea), Peng Chiong Tan (Egilea), Maherah Kamarudin (Egilea), Siti Zawiah Omar (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2021-02-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Antenatal corticosteroids (ACS) are increasingly used to improve prematurity-related neonatal outcome. A recognized and common adverse effect from administration of antenatal corticosteroid is maternal hyperglycemia. Even normal pregnancy is characterized by relative insulin resi...